Myocardial microvascular function during acute coronary artery stenosis: effect of hypertension and hypercholesterolaemia.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 2701723)

Published in Cardiovasc Res on May 07, 2009

Authors

Xiang-Yang Zhu1, Elena Daghini, Alejandro R Chade, Daniele Versari, James D Krier, Kyle B Textor, Amir Lerman, Lilach O Lerman

Author Affiliations

1: Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Articles citing this

Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis. Arterioscler Thromb Vasc Biol (2012) 1.07

Quantification of coronary microvascular resistance using angiographic images for volumetric blood flow measurement: in vivo validation. Am J Physiol Heart Circ Physiol (2011) 0.93

Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension. J Hypertens (2014) 0.91

Early experimental hypertension preserves the myocardial microvasculature but aggravates cardiac injury distal to chronic coronary artery obstruction. Am J Physiol Heart Circ Physiol (2010) 0.89

High fat feeding promotes obesity and renal inflammation and protects against post cardiopulmonary bypass acute kidney injury in swine. Crit Care (2013) 0.88

Enhanced endothelial progenitor cell angiogenic potency, present in early experimental renovascular hypertension, deteriorates with disease duration. J Hypertens (2011) 0.88

Adipose tissue remodeling in a novel domestic porcine model of diet-induced obesity. Obesity (Silver Spring) (2014) 0.88

Obesity-metabolic derangement exacerbates cardiomyocyte loss distal to moderate coronary artery stenosis in pigs without affecting global cardiac function. Am J Physiol Heart Circ Physiol (2014) 0.87

VEGF: Potential therapy for renal regeneration. F1000 Med Rep (2012) 0.83

Propofol Attenuates Small Intestinal Ischemia Reperfusion Injury through Inhibiting NADPH Oxidase Mediated Mast Cell Activation. Oxid Med Cell Longev (2015) 0.80

Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use? J Am Soc Hypertens (2013) 0.77

Adenosine receptor regulation of coronary blood flow in Ossabaw miniature swine. J Pharmacol Exp Ther (2010) 0.77

Hemodynamic determinants of perivascular collateral development in swine renal artery stenosis. Am J Hypertens (2012) 0.76

Articles cited by this

Coronary microvascular dysfunction. N Engl J Med (2007) 5.22

Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev (2007) 3.19

Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J Mol Cell Cardiol (2004) 1.93

Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation (2007) 1.90

Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation (2008) 1.88

Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries? Circulation (2003) 1.83

Pharmacological modulation of the human collateral vascular resistance in acute and chronic coronary occlusion assessed by intracoronary blood flow velocity analysis in an angioplasty model. Circulation (1997) 1.55

Relationship between pressure-derived collateral blood flow and diabetes mellitus in patients with stable angina pectoris: a study based on coronary pressure measurement. J Invasive Cardiol (2002) 1.50

Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary intervention. Eur Heart J (2004) 1.48

Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol (2001) 1.46

Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation (2004) 1.46

Importance of collateral circulation in coronary heart disease. Eur Heart J (2007) 1.45

Increased oxidative stress in experimental renovascular hypertension. Hypertension (2001) 1.44

Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension (2007) 1.38

Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol (2000) 1.38

A quantitative study of the anatomy and distribution of coronary arteries in swine in comparison with other animals and man. Cardiovasc Res (1986) 1.30

Role of oxidative stress in remodeling of the myocardial microcirculation in hypertension. Arterioscler Thromb Vasc Biol (2006) 1.16

Humoral and cellular factors responsible for coronary collateral formation. Am J Cardiol (2006) 1.14

The human coronary collateral circulation. Heart (2003) 1.08

Altered myocardial microvascular 3D architecture in experimental hypercholesterolemia. Circulation (2000) 1.07

Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity. J Am Coll Cardiol (2001) 1.03

Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension. Am J Physiol Heart Circ Physiol (2005) 1.01

Regulation of native collateral vessel dilation after coronary occlusion in the dog. Am J Physiol (1994) 1.00

CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation. Am J Physiol Heart Circ Physiol (2008) 0.97

Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol (1999) 0.96

Redox-sensitive myocardial remodeling and dysfunction in swine diet-induced experimental hypercholesterolemia. Atherosclerosis (2006) 0.95

Long-term antioxidant intervention improves myocardial microvascular function in experimental hypertension. Hypertension (2004) 0.95

Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. J Am Coll Cardiol (2000) 0.95

Minimally invasive evaluation of coronary microvascular function by electron beam computed tomography. Circulation (2000) 0.90

Expression and protective role of heme oxygenase-1 in delayed myocardial preconditioning. Ann N Y Acad Sci (2007) 0.89

Coronary collateral size, flow capacity, and growth: estimates from the angiogram in patients with obstructive coronary disease. Circulation (2002) 0.89

Coronary collateral circulation in coronary artery disease and systemic hypertension. Am J Cardiol (1991) 0.88

Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus. Coron Artery Dis (2003) 0.87

Subepicardial vasodilator reserve in the presence of critical coronary stenosis in dogs. Am J Cardiol (1980) 0.84

ST segment response to acute coronary occlusion: coronary hemodynamic and angiographic determinants of direction of ST segment shift. Circulation (1986) 0.83

Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy. Pharmacol Res (2006) 0.82

Dobutamine-induced hyperaemia inversely correlates with coronary artery stenosis severity and highlights dissociation between myocardial blood flow and oxygen consumption. Heart (2006) 0.82

Inflammatory alterations in the myocardial microcirculation. J Mol Cell Cardiol (1998) 0.81

Regional myocardial blood flow redistribution as a cause of postprandial angina pectoris. Circulation (1998) 0.77

Mending the broken heart: ischemic preconditioning-stimulated myocardial angiogenesis. J Mol Cell Cardiol (2004) 0.77

Articles by these authors

Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med (2004) 11.40

Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J (2008) 9.50

Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol (2003) 6.04

Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol (2004) 4.62

Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation (2012) 4.13

Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA (2012) 3.91

Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol (2010) 3.63

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol (2006) 3.25

Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J (2010) 3.22

Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol (2004) 3.19

Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation (2003) 2.81

The assessment of endothelial function: from research into clinical practice. Circulation (2012) 2.68

High leukocyte count is associated with peripheral vascular dysfunction in individuals with low cardiovascular risk. Circ J (2012) 2.61

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol (2006) 2.57

The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension (2008) 2.56

Myocardial bridging. Eur Heart J (2005) 2.56

Chronic proteasome inhibition contributes to coronary atherosclerosis. Circ Res (2007) 2.55

Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol (2007) 2.53

Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol (2003) 2.52

Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation (2007) 2.43

Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation (2009) 2.24

Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: a long-term follow-up study. J Am Coll Cardiol (2005) 2.21

Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation (2006) 2.18

Comparison of mathematic models for assessment of glomerular filtration rate with electron-beam CT in pigs. Radiology (2007) 2.17

Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension (2010) 2.17

Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: comparison with electron-beam CT. Radiology (2007) 2.14

Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens (2005) 2.12

The long-term effect of coronary stenting on epicardial and microvascular endothelial function. Circ Cardiovasc Interv (2012) 2.03

Distinct renal injury in early atherosclerosis and renovascular disease. Circulation (2002) 2.01

Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol (2005) 2.00

Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care (2009) 1.91

Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol (2003) 1.91

Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol (2006) 1.90

Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation (2007) 1.89

The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension. J Hypertens (2009) 1.88

Ubiquitin and ubiquitin-like proteins in protein regulation. Circ Res (2007) 1.87

Cortical microvascular remodeling in the stenotic kidney: role of increased oxidative stress. Arterioscler Thromb Vasc Biol (2004) 1.87

Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers. Br J Clin Pharmacol (2009) 1.81

Effect of long-term hormone replacement therapy on coronary endothelial function in postmenopausal women. Mayo Clin Proc (2004) 1.80

Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol (2008) 1.78

Simvastatin abates development of renal fibrosis in experimental renovascular disease. J Hypertens (2008) 1.78

Expression of lipoprotein-associated phospholipase A(2) in carotid artery plaques predicts long-term cardiac outcome. Eur Heart J (2009) 1.77

Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. Eur Heart J (2013) 1.76

Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease. J Am Coll Cardiol (2008) 1.74

Acute heart failure in apical ballooning syndrome (TakoTsubo/stress cardiomyopathy): clinical correlates and Mayo Clinic risk score. J Am Coll Cardiol (2011) 1.74

Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol (2004) 1.70

Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia. FASEB J (2006) 1.69

Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis. Hypertension (2008) 1.67

Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression. J Am Coll Cardiol (2009) 1.67

Human renovascular disease: estimating fractional tissue hypoxia to analyze blood oxygen level-dependent MR. Radiology (2013) 1.65

Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J (2006) 1.63

Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab (2003) 1.61

Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effect. Atherosclerosis (2011) 1.59

Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque. Eur Heart J (2013) 1.59

Role of circulating osteogenic progenitor cells in calcific aortic stenosis. J Am Coll Cardiol (2012) 1.59

Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain? J Am Coll Cardiol (2003) 1.59

Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. Eur Heart J (2009) 1.58

Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation (2002) 1.57

Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol (2006) 1.56